Obsessive-Compulsive Disorder
Also known as: OCD, Disorder, Syndrome, Diseases, Condition
Methodology & AI Transparency ⓘ
Obsessive-Compulsive Disorder Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What is obsessive-compulsive disorder (OCD)? Obsessive-compulsive disorder (OCD) is a mental disorder in which you have thoughts (obsessions) and behaviors (compulsions) that occur over and over.
- 2 Real-world patient consensus: Mapped to Anxiety, OCD & Trauma Disorders under ICD-10-CM F42.9 for Obsessive-Compulsive Disorder clinical workups.
- 3 Typical cash cost range: Workup highlights for Obsessive-Compulsive Disorder (F42.9): non-habit-forming pharmacotherapy planning [Obsessive-Compulsive Disorder F42.9].
- 4 Top reported side effects / signs: Longitudinal Obsessive-Compulsive Disorder monitoring tracks GAD-7 Anxiety Severity in Obsessive-Compulsive Disorder (F42.9: Score) toward < 4 (minimal anxiety) (F42.9).
Ask our AI Specialists anything about Obsessive-Compulsive Disorder
What Is Obsessive-Compulsive Disorder?
What is obsessive-compulsive disorder (OCD)? Obsessive-compulsive disorder (OCD) is a mental disorder in which you have thoughts (obsessions) and behaviors (compulsions) that occur over and over. They interfere with your life, but you cannot control or stop them. It's a myth that OCD just means being neat. Cleaning can be one symptom, but OCD more often involves getting stuck on a particular action you feel compelled to repeat, rather than simply staying organized. These obsessions and compulsions can shift over time. What causes obsessive-compulsive disorder (OCD)? The cause of OCD is unknown.
Pathophysiology, Underlying Causes & Clinical Presentation
Mechanistic hallmarks of Obsessive-Compulsive Disorder (F42.9) center on amygdala threat-circuit hyperreactivity [Obsessive-Compulsive Disorder F42.9]. Cross-referenced with NIH MeSH (Obsessive-Compulsive Disorder), targeted anxiety & ptsd interventions aim to normalize GAD-7 Anxiety Severity in Obsessive-Compulsive Disorder (F42.9: Score).
Common Symptoms & Clinical Signs
- • Temperament. Other studies found that people who are shy, often unhappy, or anxious and depressed as children may be more likely to develop OCD
- • Obsessions are repeated thoughts, urges, or mental images that cause anxiety . They may involve things such as • Fear of germs or contamination
- • Presentation of Obsessive-Compulsive Disorder (F42.9): chronic neck, jaw, in Obsessive-Compulsive Disorder (F42.9: and shoulder muscle)
- • Secondary Obsessive-Compulsive Disorder clinical sign: avoidance of triggers, in Obsessive-Compulsive Disorder (F42.9: intrusive trauma memories,)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Obsessive-Compulsive Disorder Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | F42.9 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Anxiety, OCD & Trauma Disorders | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: GAD-7 Anxiety Severity in Obsessive-Compulsive Disorder (F42.9: Score) | < 4 (minimal anxiety) (F42.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Resting Heart Rate in Obsessive-Compulsive Disorder (F42.9: Variability (HRV)) | Stable upward personal trend (F42.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: TSH & Ferritin in Obsessive-Compulsive Disorder (F42.9: Rule-Out) | TSH 0.8–2.5 mIU/L; Ferritin > 50 ng/mL (F42.9) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Obsessive-Compulsive Disorder
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Clomipramine Hydrochloride Anafranil • RxCUI 857297 | Tricyclic Antidepressant | 74% | $0.1694 | $ 6.77 /mo |
| Fluvoxamine Maleate Luvox • RxCUI 903873 | Serotonin Reuptake Inhibitor | 93% | $3.6629 | $ 7.45 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Obsessive-Compulsive Disorder)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive We found no evidence supporting the efficacy of the adjunctive use of NAC in OCD. Progress in neuro-psychopharmacology & biological psychiatry • 2022-07-13 • Phase III Randomized Trial | N = 98 | 88/100 | PMID 35304155 ↗ |
| Managing Generalized anxiety: Can Executive functioning Make a Real Difference? (What New Research Reveals) An updated framework specific to GAD is therefore needed to clarify the underlying cognitive mechanisms underlying this condition. Journal of affective disorders • 2025-11-15 • Meta-Analysis | Multi-cohort | 86/100 | PMID 40513710 ↗ |
| Can This Approach Help? Inside the Latest Research on Testing a Novel Deliberate Practice Intervention to Improve Diagnostic Reasoning The study enrolled 72 physicians (mean [SD] age, 43.3 [9.4] years; 44 men [61%]) but limited registration of physicians in the intervention group to 30 because of the availability of the coaches. JAMA network open • 2023-05-01 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 37195666 ↗ |
Obsessive-Compulsive Disorder Patient Community & “People Like Me” Threads
Filter Obsessive-Compulsive Disorder community threads and patient logs by age, biological sex, dosage, and treatment duration.